Immediate Impact
58 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
Works of Michael Metz being referenced
Australasian Guideline (2nd Edition): an Annex to the CLSI and UK Guidelines for the Performance of the Sweat Test for the Diagnosis of Cystic Fibrosis.
2017
Donepezil for Alzheimer's Disease — The donald study — a multicenter 24 weeks clinical trial in Germany
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael Metz | 131 | 55 | 69 | 138 | 71 | 38 | 478 | |
| Manisha Singh | 38 | 118 | 39 | 87 | 33 | 45 | 468 | |
| Khaled Shawwa | 184 | 140 | 67 | 68 | 36 | 32 | 476 | |
| Sunita Saxena | 48 | 21 | 18 | 83 | 22 | 38 | 518 | |
| Miho Kimachi | 97 | 104 | 33 | 43 | 36 | 37 | 502 | |
| Kağan Huysal | 92 | 59 | 68 | 77 | 12 | 34 | 544 | |
| Patrick Heger | 374 | 6 | 172 | 43 | 21 | 23 | 541 | |
| G. Godiris-Petit | 460 | 92 | 80 | 54 | 13 | 30 | 570 | |
| Nairo Massakazu Sumita | 60 | 22 | 29 | 63 | 26 | 48 | 416 | |
| Khalid Serraj | 63 | 29 | 43 | 51 | 6 | 38 | 487 | |
| Yun Huang | 86 | 84 | 59 | 39 | 9 | 27 | 446 |
All Works
Login with ORCID to disown or claim papers
Loading papers...